Protect the Future of Medical Innovation

Imagine a world where breakthroughs in cancer treatments, ALS cures, or advancements for rare diseases are stifled—not from lack of knowledge, but from a lack of resources to bring those innovations to life. This is the stark reality we face under the provisions of the Inflation Reduction Act (IRA), which imposes harmful Medicare price controls on life-saving medicines.

These so-called “negotiations” are anything but fair. Pharmaceutical companies are forced into accepting Medicare's dictated rates or face penalties that could reach 1,900% of a drug's sales revenue. This punitive approach is cutting into the funding that drives critical research and development (R&D), creating ripple effects across the healthcare industry.

Leading companies like Bristol Myers Squibb and Eli Lilly have already scaled back on new projects, halting work on promising cancer and rare disease treatments. Experts warn that up to 135 fewer life-saving drugs could reach patients by 2039 due to lost innovation. The true cost? Prolonged patient suffering and an $18 trillion hit to health advancements over the next 15 years.

If we don’t act now, we risk losing access to breakthrough treatments that improve and save millions of lives.

We need Congress to reverse the IRA’s harmful provisions and protect policies that fuel innovation. Sign this petition to send a clear message that supporting medical progress starts with enabling the research that drives it.

Your voice matters. Join us in advocating for patients and a healthier future today!